Serum IL-1ra, a novel biomarker predicting olanzapine-induced hypercholesterolemia and hyperleptinemia in schizophrenia

Lin, Yezhe; Peng, Yanmin; He, Shen; Xu, Jinjie; Shi, Yuan; Su, Yousong; Zhu, Cuizhen; Zhang, Xinyi; Zhou, Rubai; Cui, Donghong

doi:10.1016/j.pnpbp.2018.01.020

Title: Serum IL-1ra, a novel biomarker predicting olanzapine-induced hypercholesterolemia and hyperleptinemia in schizophrenia

Full Record
Other Related Research

Authors:

Lin, Yezhe; Peng, Yanmin; He, Shen; Xu, Jinjie; Shi, Yuan; Su, Yousong; Zhu, Cuizhen;

; Zhou, Rubai; Cui, Donghong

Publication Date:: 2018-06-01

Sponsoring Org.:: USDOE Office of Electricity (OE), Advanced Grid Research & Development. Power Systems Engineering Research

OSTI Identifier:: 1437817

Grant/Contract Number:: 2017YFC0909200; 2016YFC0906400

Resource Type:: Published Article

Journal Name:: Progress in Neuro-Psychopharmacology and Biological Psychiatry

Additional Journal Information:: Journal Name: Progress in Neuro-Psychopharmacology and Biological Psychiatry Journal Volume: 84 Journal Issue: PA; Journal ID: ISSN 0278-5846

Publisher:: Elsevier

Country of Publication:: United Kingdom

Language:: English

Citation Formats


                    Lin, Yezhe, Peng, Yanmin, He, Shen, Xu, Jinjie, Shi, Yuan, Su, Yousong, Zhu, Cuizhen, Zhang, Xinyi, Zhou, Rubai, and Cui, Donghong. Serum IL-1ra, a novel biomarker predicting olanzapine-induced hypercholesterolemia and hyperleptinemia in schizophrenia.  United Kingdom: N. p., 2018. 
Web.  doi:10.1016/j.pnpbp.2018.01.020.

Copy to clipboard


                    Lin, Yezhe, Peng, Yanmin, He, Shen, Xu, Jinjie, Shi, Yuan, Su, Yousong, Zhu, Cuizhen, Zhang, Xinyi, Zhou, Rubai, & Cui, Donghong. Serum IL-1ra, a novel biomarker predicting olanzapine-induced hypercholesterolemia and hyperleptinemia in schizophrenia.  United Kingdom.  https://doi.org/10.1016/j.pnpbp.2018.01.020

Copy to clipboard


                    Lin, Yezhe, Peng, Yanmin, He, Shen, Xu, Jinjie, Shi, Yuan, Su, Yousong, Zhu, Cuizhen, Zhang, Xinyi, Zhou, Rubai, and Cui, Donghong. Fri .  
"Serum IL-1ra, a novel biomarker predicting olanzapine-induced hypercholesterolemia and hyperleptinemia in schizophrenia".  United Kingdom.  https://doi.org/10.1016/j.pnpbp.2018.01.020.

Copy to clipboard


                    
@article{osti_1437817,

  title        = {Serum IL-1ra, a novel biomarker predicting olanzapine-induced hypercholesterolemia and hyperleptinemia in schizophrenia},

  author       = {Lin, Yezhe and Peng, Yanmin and He, Shen and Xu, Jinjie and Shi, Yuan and Su, Yousong and Zhu, Cuizhen and Zhang, Xinyi and Zhou, Rubai and Cui, Donghong},

  abstractNote = {},

  doi          = {10.1016/j.pnpbp.2018.01.020},

  journal      = {Progress in Neuro-Psychopharmacology and Biological Psychiatry},

  number       = PA,

  volume       = 84,

  place        = {United Kingdom},

  year         = {2018},

  month        = {6}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Publisher's Version of Record
https://doi.org/10.1016/j.pnpbp.2018.01.020

Other availability

Search WorldCat to find libraries that may hold this journal

Citation Metrics:

Cited by: 1 work

Citation information provided by
Web of Science

Save / Share:

Export Metadata

Save to My Library

Similar Records in DOE PAGES and OSTI.GOV collections:

Serum biomarkers for diagnosis and prediction of type 1 diabetes

Journal Article Yi, Lian ; Swensen, Adam C. ; Qian, Wei-Jun - Translational Research

Type 1 diabetes (T1D) culminates in the autoimmune destruction of the pancreatic ß-cells, leading to insufficient production of insulin and development of hyperglycemia. Serum biomarkers including glucose, glycated molecules, c-peptide, and autoantibodies have been well established to diagnose T1D from other subtypes of diabetes. However, these molecules often mark a late stage of the disease when ~90% of the pancreatic insulin-producing ß-cells have already been lost. With the prevalence of T1D increasing worldwide and because of the physical and psychological burden induced by this disease, there is a great need for prognostic biomarkers to predict T1D development or progression. Thismore »« less
https://doi.org/10.1016/j.trsl.2018.07.009
Potential serum biomarkers for the prediction of the efficacy of escitalopram for treating depression

Journal Article Xu, Yuhao ; Wei, Hong ; Zhu, Yuanyuan ; ... - Journal of Affective Disorders
Cited by 2
https://doi.org/10.1016/j.jad.2019.03.008
Serum biomarkers for diagnosis and prediction of type 1 diabetes

Journal Article Yi, Lian ; Swensen, Adam C. ; Qian, Wei -Jun - Translational Research

Here, Type 1 diabetes (T1D) culminates in the autoimmune destruction of the pancreatic β-cells, leading to insufficient production of insulin and development of hyperglycemia. Serum biomarkers including a combination of glucose, glycated molecules, c-peptide, and autoantibodies have been well established for the diagnosis of T1D. However, these molecules often mark a late stage of the disease when ~90% of the pancreatic insulin-producing β-cells have already been lost. With the prevalence of T1D increasing worldwide and because of the physical and psychological burden induced by this disease, there is a great need for prognostic biomarkers to predict T1D development or progression.more »« less
Cited by 1
https://doi.org/10.1016/j.trsl.2018.07.009

Full Text Available
In vivo administration of IL-1 induces thymic hypoplasia and increased levels of serum corticosterone

Journal Article Morrissey, P J ; Charrier, K ; Alpert, A ; ... - J. Immunol.; (United States)

Administration of IL-1 alpha or IL-1 beta to normal mice induces a decrease in thymic cellularity, the magnitude of which depends on the number of injections and dose of IL-1. Twice daily injections of 200 ng of IL-1 alpha or -beta for 4 days results in a 90% decrease in thymic cellularity, which regenerated after cessation of treatment. Study of thymocyte subpopulations revealed that the number of CD4+/CD8+ thymocytes was dramatically decreased in IL-1-treated mice. Functional assessment of the CD4-/CD8- population from treated animals showed that these cells had adequate mitogenic responses in vitro and that the proportion of thesemore »« less
Transforming Growth Factor β-1 (TGF-β1) Is a Serum Biomarker of Radiation Induced Fibrosis in Patients Treated With Intracavitary Accelerated Partial Breast Irradiation: Preliminary Results of a Prospective Study

Journal Article Boothe, Dustin L. ; Coplowitz, Shana ; Greenwood, Eleni ; ... - International Journal of Radiation Oncology, Biology and Physics

Purpose: To examine a relationship between serum transforming growth factor β -1 (TGF-β1) values and radiation-induced fibrosis (RIF). Methods and Materials: We conducted a prospective analysis of the development of RIF in 39 women with American Joint Committee on Cancer stage 0-I breast cancer treated with lumpectomy and accelerated partial breast irradiation via intracavitary brachytherapy (IBAPBI). An enzyme-linked immunoassay (Quantikine, R and D, Minneapolis, MN) was used to measure serum TGF-β1 before surgery, before IBAPBI, and during IBAPBI. Blood samples for TGF-β1 were also collected from 15 healthy, nontreated women (controls). The previously validated tissue compliance meter (TCM) was usedmore »« less
https://doi.org/10.1016/J.IJROBP.2013.08.045

Similar Records